Lazard Asset Management LLC boosted its holdings in Genpact Limited (NYSE:G - Free Report) by 115.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 80,319 shares of the business services provider's stock after buying an additional 43,011 shares during the quarter. Lazard Asset Management LLC's holdings in Genpact were worth $3,448,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Coppell Advisory Solutions LLC boosted its position in shares of Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares during the period. SRH Advisors LLC bought a new position in shares of Genpact in the 4th quarter valued at about $26,000. Atlas Capital Advisors Inc. boosted its holdings in shares of Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the period. Manchester Capital Management LLC purchased a new stake in shares of Genpact in the fourth quarter valued at $38,000. Finally, GeoWealth Management LLC lifted its stake in Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after purchasing an additional 583 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.
Insider Buying and Selling at Genpact
In other Genpact news, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, with a total value of $87,940.00. Following the acquisition, the director now directly owns 2,000 shares of the company's stock, valued at approximately $87,940. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on G shares. Mizuho upped their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC dropped their target price on shares of Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Robert W. Baird dropped their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Finally, Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, Genpact currently has a consensus rating of "Hold" and an average price target of $50.71.
Get Our Latest Report on G
Genpact Stock Up 0.7%
Shares of Genpact stock traded up $0.33 on Tuesday, reaching $44.43. The stock had a trading volume of 1,145,587 shares, compared to its average volume of 1,367,191. The company has a 50 day moving average price of $47.92 and a 200 day moving average price of $47.30. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76. The stock has a market capitalization of $7.77 billion, a P/E ratio of 15.64, a P/E/G ratio of 1.84 and a beta of 1.02.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The firm had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter in the previous year, the firm earned $0.73 EPS. The company's quarterly revenue was up 7.4% compared to the same quarter last year. As a group, equities research analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.